Clinical Trials

On the heels of Australian legislation to allow cannabis cultivation for medical or scientific purposes, MGC Pharmaceuticals is reportedly preparing to enter the Australian market to grow cannabis, extend its clinical trial program and expand outlets for its line of cannabis-based cosmetics. MGC recently released a five-point plan for the local market and is in […]

Western University researchers have discovered that a chemical found in marijuana may be an effective treatment for schizophrenia by reducing psychiatric symptoms without the side effects of traditional medication. The study shows cannabidiol, or CBD, affects the brain in a way that makes it treatment option for schizophrenia. Paradoxially, this research comes just months after […]

GRAND RAPIDS, Mich. (WOOD) — A big development in the treatment of epilepsy in children is about to get underway on Grand Rapids’ Medical Mile. Helen Devos Children’s Hospital is in the final stages of approval to start testing cannabidiol oil in children who suffer from neurological disorders like epilepsy, 24 Hour News 8 has […]

by

The United States Drug Enforcement Administration (DEA) has given formal approval to a controlled clinical trial to study the effectiveness of whole-plant cannabis as a treatment for post-traumatic stress disorder (PTSD) in military veterans, the California-based non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) announced last week. Post-traumatic stress disorder is an anxiety disorder that impacts an estimated eight […]

by

FORTUNE – The unofficial pot-smoking holiday of April 20 may be over, but marijuana advocates got another reason to celebrate on Thursday. The U.S. Drug Enforcement Administration for the first time approved smoking marijuana as legitimate medical research. The DEA green-lit a clinical trial of smoked marijuana for the treatment of post-traumatic stress disorder (PTSD) […]

by

The U.S. Drug Enforcement Agency agreed for the first time ever this week to let researchers conduct clinical trials with marijuana to examine the potential benefits of using the plant to treat post-traumatic stress disorder. A California-based nonprofit research group, the Multidisciplinary Approach to Psychedelic Studies (MAPS), announced on Thursday that the DEA will allow […]

by

The DEA appears to have reversed its staunch opposition to smoking marijuana. The regulator has, for the first time ever, approved smoking marijuana as legitimate medical research, which might make it easy for medical practitioners to prescribe smoking weed as a line of treatment. Currently, the trial is restricted to PTSD, but if the results […]

by

GW Pharmaceuticals plc (GWPH) is expected to report Q2 earnings estimated on Tuesday 05/17/2016. The company operates in the Drug Manufacturers – Major industry. GW Pharmaceuticals PLC is engaged in the research, development and commercialisation of cannabinoid prescription medicines using botanical extracts derived from the Cannabis Sativa plant. EXPECTATIONS: Analysts are looking for earnings per […]

by

The unofficial pot-smoking holiday of April 20 may be over, but marijuana advocates got another reason to celebrate on Thursday. The U.S. Drug Enforcement Administration for the first time approved smoking marijuana as legitimate medical research. The DEA green-lit a clinical trial of smoked marijuana for the treatment of post-traumatic stress disorder (PTSD) in American […]

by

It’s April 20, which means the worldwide celebration of marijuana culture appropriately known as 4/20 is again upon us. “Four-twenty” originated as a time – 4:20 p.m. – when a group in San Rafael, California met regularly in the 1970s to search for an elusive cannabis crop nearby. They never found it, but 4/20 instead […]

by